Patent · US Active

Adrenaline pharmaceutical solution for an injection device

US11439605B2 · kind B2 · utility

0Cited by

1References

15Claims

0Family size

Assignee

CROSSJECT · FR

Inventors

Eric Teillaud · Talant, FR
Nicolas Baumard · Dijon, FR
Audrey Ressejeac · Station de Ski de Réallon, FR

Key dates

Filing date	Apr 15, 2020
Grant date	Sep 13, 2022
Priority date	—
Expiry date	Apr 15, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An adrenaline pharmaceutical solution including at least: adrenaline or a pharmaceutically-acceptable salt thereof; vitamin E TPGS; a chelating agent; a solvent. The method also relates to its use in the treatment of anaphylactic shocks, cardiac arrests, asthma and cardiocirculatory distresses. The method also concerns an injection kit including an injection device and this pharmaceutical solution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.